Align Technology, Inc. $ALGN Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 6.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 82,712 shares of the medical equipment provider’s stock after buying an additional 5,032 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Align Technology were worth $15,660,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in ALGN. Cromwell Holdings LLC raised its holdings in Align Technology by 2,900.0% in the second quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 174 shares in the last quarter. SVB Wealth LLC acquired a new position in Align Technology during the 1st quarter worth $36,000. Farther Finance Advisors LLC increased its position in shares of Align Technology by 42.2% in the 2nd quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 92 shares during the last quarter. Covestor Ltd raised its stake in shares of Align Technology by 18.8% in the 1st quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock valued at $78,000 after purchasing an additional 78 shares in the last quarter. Finally, Quarry LP lifted its position in shares of Align Technology by 197.7% during the first quarter. Quarry LP now owns 765 shares of the medical equipment provider’s stock worth $122,000 after purchasing an additional 508 shares during the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology Price Performance

NASDAQ:ALGN opened at $133.73 on Friday. The firm has a market capitalization of $9.69 billion, a P/E ratio of 25.92, a P/E/G ratio of 1.49 and a beta of 1.84. The business has a 50 day simple moving average of $132.74 and a 200 day simple moving average of $160.91. Align Technology, Inc. has a 12-month low of $122.00 and a 12-month high of $246.19.

Align Technology (NASDAQ:ALGN) last issued its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.23. The firm had revenue of $995.69 million for the quarter, compared to analyst estimates of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The firm’s revenue for the quarter was up 1.8% on a year-over-year basis. During the same period last year, the company earned $2.35 earnings per share. Align Technology has set its Q4 2025 guidance at EPS. Research analysts anticipate that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology announced that its Board of Directors has authorized a stock buyback plan on Tuesday, August 5th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the medical equipment provider to purchase up to 2% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Zacks Research upgraded Align Technology from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 30th. Stifel Nicolaus set a $200.00 price target on Align Technology in a report on Thursday, October 30th. Mizuho dropped their price target on Align Technology from $210.00 to $170.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. Evercore ISI lifted their price objective on shares of Align Technology from $160.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Finally, Piper Sandler reiterated an “overweight” rating and set a $200.00 target price (up previously from $190.00) on shares of Align Technology in a research note on Thursday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $175.45.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.